644 Shares in STERIS plc $STE Purchased by Trust Co. of Toledo NA OH

Trust Co. of Toledo NA OH acquired a new position in STERIS plc (NYSE:STE) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 644 shares of the medical equipment provider’s stock, valued at approximately $155,000.

Other institutional investors also recently bought and sold shares of the company. Geneos Wealth Management Inc. boosted its holdings in STERIS by 416.0% in the 1st quarter. Geneos Wealth Management Inc. now owns 129 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 104 shares during the last quarter. Grove Bank & Trust boosted its holdings in STERIS by 4,733.3% in the 1st quarter. Grove Bank & Trust now owns 145 shares of the medical equipment provider’s stock worth $33,000 after buying an additional 142 shares during the last quarter. Zions Bancorporation National Association UT acquired a new stake in STERIS in the 1st quarter worth about $37,000. ORG Wealth Partners LLC acquired a new stake in STERIS in the 1st quarter worth about $43,000. Finally, Golden State Wealth Management LLC boosted its holdings in STERIS by 503.0% in the 1st quarter. Golden State Wealth Management LLC now owns 199 shares of the medical equipment provider’s stock worth $45,000 after buying an additional 166 shares during the last quarter. 94.69% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

STE has been the topic of several research analyst reports. KeyCorp lifted their price objective on STERIS from $277.00 to $288.00 and gave the stock an “overweight” rating in a report on Tuesday, July 22nd. Morgan Stanley boosted their target price on STERIS from $276.00 to $295.00 and gave the stock an “overweight” rating in a report on Friday, August 8th. Wall Street Zen upgraded STERIS from a “buy” rating to a “strong-buy” rating in a report on Sunday, September 14th. Finally, Weiss Ratings restated a “buy (b-)” rating on shares of STERIS in a report on Saturday, September 27th. Seven analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $273.50.

STERIS Trading Down 1.6%

STE opened at $235.67 on Friday. STERIS plc has a one year low of $200.98 and a one year high of $253.00. The stock has a market capitalization of $23.21 billion, a PE ratio of 36.09 and a beta of 1.01. The business’s 50 day moving average price is $244.33 and its 200 day moving average price is $235.89. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.53 and a current ratio of 2.22.

STERIS (NYSE:STE) last released its quarterly earnings data on Wednesday, August 6th. The medical equipment provider reported $2.34 EPS for the quarter, beating analysts’ consensus estimates of $2.32 by $0.02. STERIS had a return on equity of 14.17% and a net margin of 11.61%.The firm had revenue of $1.40 billion for the quarter, compared to analysts’ expectations of $1.36 billion. During the same period in the prior year, the firm posted $2.03 earnings per share. The firm’s quarterly revenue was up 8.8% on a year-over-year basis. As a group, equities research analysts expect that STERIS plc will post 9.08 EPS for the current year.

STERIS Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 26th. Investors of record on Thursday, September 4th were issued a $0.63 dividend. This is a boost from STERIS’s previous quarterly dividend of $0.57. This represents a $2.52 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date was Thursday, September 4th. STERIS’s payout ratio is currently 38.59%.

Insider Transactions at STERIS

In related news, CAO Karen L. Burton sold 7,900 shares of the company’s stock in a transaction that occurred on Monday, August 11th. The stock was sold at an average price of $241.73, for a total value of $1,909,667.00. Following the transaction, the chief accounting officer directly owned 5,994 shares in the company, valued at approximately $1,448,929.62. This represents a 56.86% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, VP Renato Tamaro sold 3,204 shares of the company’s stock in a transaction that occurred on Wednesday, August 20th. The shares were sold at an average price of $249.24, for a total value of $798,564.96. Following the completion of the transaction, the vice president owned 7,221 shares in the company, valued at $1,799,762.04. This represents a 30.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 18,868 shares of company stock valued at $4,585,389 in the last ninety days. 1.07% of the stock is currently owned by corporate insiders.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.